Evidence map›Paper›PMID 33013617›Full record

ArticleFrontiers in neurology2020

Readaptation Treatment of Mal de Debarquement Syndrome With a Virtual Reality App: A Pilot Study.

Sergei B Yakushin, Reilly Zink, Brian C Clark, Chang Liu

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05460520 (Developing Robust Treatment Options for Mal de Débarquement Syndrome), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05460520 narecruitingnot on this mapstarted 2023, after this paper: background citation

Developing Robust Treatment Options for Mal de Débarquement Syndrome

TypeinterventionalSponsorIcahn School of Medicine at Mount SinaiRan2023 to 2027Enrolled200ConditionsMal de Débarquement SyndromeArmsVOR Readaptation, VOR Habituation, Visual Motion Desensitization, Opposing visual motion stimulus
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Creating Informed Interest in Mal De Débarquement Syndrome.The primary care companion for CNS disorders · 2023
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sergei B YakushinDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Reilly ZinkOhio Musculoskeletal and Neurological Institute (OMNI), Ohio University, Athens, OH, United States.
Brian C ClarkOhio Musculoskeletal and Neurological Institute (OMNI), Ohio University, Athens, OH, United States.
Chang LiuOhio Musculoskeletal and Neurological Institute (OMNI), Ohio University, Athens, OH, United States.
Ohio University · USIcahn School of Medicine at Mount Sinai · US

Funding

Treatment of Mal de Debarquement Syndrome (MdDS) by habituation of Velocity Storage.R21DC018390 · NIDCD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI YAKUSHIN, SERGEI · 2020 to 2021
$466k
NIDCD NIH HHS R21 DC018390
6 · The paper itself

Abstract

Mal de Debarquement syndrome (MdDS) is composed of constant phantom sensations of motion, which are frequently accompanied by increased sensitivity to light, inability to walk on a patterned floor, the sensation of ear fullness, head pressure, anxiety, and depression. This disabling condition generally occurs in premenopausal women within 2 days after prolonged passive motion (e.g., travel on a cruise ship, plane, or in a car). It has been previously hypothesized that MdDS is the result of maladaptive changes in the polysynaptic vestibulo-ocular reflex (VOR) pathway called velocity storage. Past research indicates that full-field optokinetic stimulation is an optimal way to activate velocity storage. Unfortunately, such devices are typically bulky and not commonly available. We questioned whether virtual reality (VR) goggles with a restricted visual field could effectively simulate a laboratory environment for MdDS treatment. A stripes program for optokinetic stimulation was implemented using Google Daydream Viewer. Five female patients (42 ± 10 years; range 26-50), whose average MdDS symptom duration was 2 months, participated in this study. Four patients had symptoms triggered by prolonged passive motion, and in one, symptoms spontaneously occurred. Symptom severity was self-scored by patients on a scale of 0-10, where 0 is no symptoms at all and 10 is the strongest symptoms that the patient could imagine. Static posturography was obtained to determine objective changes in body motion. The treatment was considered effective if the patient's subjective score improved by at least 50%. All five patients reported immediate improvement. On 2-month follow-ups, symptoms returned only in one patient. These data provide proof of concept for the limited-visual-field goggles potentially having clinical utility as a substitute for full-field optokinetic stimulation in treating patients with MdDS in clinics or via telemedicine.

Indexed as

bobbingMal de Debarquement syndromereadaptationrockingswayingvelocity storage

Identifiers

PMID33013617
PMCPMC7461907
OpenAlexW3065550625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.